CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis

G de Laurentiis1, L Vitiello, L Racioppi

  • 1Dept of Respiratory Medicine, AO Monaldi, Second University of Naples, Naples, Italy.

Insights

Pulmonary alveolar microlithiasis (PAM) involves a gene mutation affecting sodium phosphate co-transporter. Familial PAM shows a CD8+ T-cell accumulation in the lungs, suggesting an immune response linked to genetics.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Genetics

Background:

  • Pulmonary alveolar microlithiasis (PAM) is a rare lung disease characterized by calcium phosphate microlith accumulation.
  • Recent discoveries link PAM to mutations in the sodium phosphate co-transporter gene in alveolar epithelial cells.
  • The clinical impact of these genetic mutations and the associated immune response in familial PAM remain largely uncharacterized.

Observation:

  • Bronchoalveolar lavage fluid analysis from two siblings with PAM revealed lymphocytic alveolitis.
  • An accumulation of CD8+ T-cells was observed in the affected lung tissue.
  • Spectratyping indicated an oligoclonal T-cell population with restricted T-cell receptor (TCR) gene usage.

Findings:

  • Familial PAM exhibits a distinct pulmonary immune cell profile, specifically a lymphocytic alveolitis with CD8+ T-cell predominance.
  • The T-cell response in the bronchoalveolar compartment appears oligoclonal, suggesting a targeted immune reaction.
  • Peripheral blood T-cell populations did not show similar abnormalities, localizing the immune dysregulation to the lungs.

Implications:

  • The findings suggest a CD8-mediated maladaptive immune response may contribute to the pathogenesis of familial PAM.
  • This immune dysregulation, potentially linked to the genetic background, warrants further investigation in PAM.
  • Understanding the interplay between genetics and immune response could lead to novel therapeutic strategies for rare lung diseases like PAM.

Related Concept Videos

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Alveoli and Alveolar Ducts01:26

Alveoli and Alveolar Ducts

The respiratory zone of the human body, which stands in contrast to the conducting zone, comprises the structures that actively participate in the exchange of gases. The initiation of this zone is marked by the terminal bronchioles converging into respiratory bronchioles, the tiniest bronchiole classification. The respiratory bronchioles give way to the alveolar ducts that opens into a congregation of alveoli. Actively involved in gas exchange, alveoli resemble tiny sacs similar to clusters of...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.